SRPT vs VVV · rev $1.13B vs P/E 51, rev $1.71B
Sarepta Therapeutics Inc (SRPT) versus Valvoline Inc (VVV) — a side-by-side from cached financials, not a winner call.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Valvoline Inc (VVV) is a auto & truck dealerships company listed on NYSE.
Latest reported SRPT revenue for 2026-06-30 was $1.13B. Net income was $326.1M. Revenue was up 54.9% from 2026-03-31 to 2026-06-30. SRPT currently screens at market cap $2.34B.
Latest reported VVV revenue for 2025-09-30 was $1.71B. Net income was $210.7M. VVV currently screens at market cap $4.84B and trailing P/E 50.6.
SRPT currently screens at market cap $2.34B. VVV currently screens at market cap $4.84B and trailing P/E 50.6.
Not investment advice. Open the SRPT and VVV stock pages for the full models.
Not investment advice.